StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Pseudoephedrine Hydrochloride

HCID 9581
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
345-78-8
Standard-SMILES
CN[C@@H](C)[C@@H](O)c1ccccc1.Cl
InChIKey
BALXUFOVQVENIU-KXNXZCPBSA-N
Summenformel
C10H16ClNO
Durchschnittliche Molmasse
201,69 g/mol
Monoisotopische Masse
201,0920418

Überblick

Pseudoephedrine Hydrochloride is the hydrochloride salt form of pseudoephedrine, a phenethylamine and an diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine hydrochloride displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion.

Namen und Bezeichner

Bevorzugter Name
Pseudoephedrine Hydrochloride
IUPAC
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride

Namen und Synonyme

PSEUDOEPHEDRINE HYDROCHLORIDEPseudoephedrine HclRhinalairOtrinolNovafed345-78-8d-Pseudoephedrine hydrochlorideSudafed 12 HourGalsudSudafed PlusSudafed 24 HourEfidac 24
Weitere Namen anzeigen
L(+)-Pseudoephedrine hydrochloride6V9V2RYJ8NNSC-33634Topcare 12 hour decongestantNSC-106567GALPSEUDD-(alpha-(1-Methylamino)ethyl)benzyl alcohol hydrochlorideDTXSID10889343

Datenbank-Bezeichner

CAS
345-78-8
PubChem CID
9581
DTXSID
DTXSID10889343
ChEMBL
CHEMBL1200724
UNII
6V9V2RYJ8N
EC Number
206-462-1

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
32,3 Ų
H-Brücken-Donoren
3
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
3
Schwere Atome
13
Formalladung
0
Komplexität
121

Experimentelle und physikochemische Eigenschaften

Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section132.1 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 261 reports by companies from 24 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 2 Einträge

REACH registered substance: Pseudoephedrine hydrochloride (EC: 206-462-1)

Pseudoephedrine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-,hydrochloride, [S-(R*,R*)]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Exposure RoutesPseudoephedrine is readily and almost completely absorbed from the GI tract and there is no evidence of first-pass metabolism.
Toxicity Summary · 1 Eintrag

Pseudoephedrine acts directly on both alpha- and, to a lesser degree, beta-adrenergic receptors. Through direct action on alpha-adrenergic receptors in the mucosa of the respiratory tract, pseudoephedrine produces vasoconstriction. Pseudoephedrine relaxes bronchial smooth muscle by stimulating beta2-adrenergic receptors. Like ephedrine, pseudoephedrine releasing norepinephrine from its storage sites, an indirect effect. This is its main and direct mechanism of action. The displaced noradrenaline is released into the neuronal synapse where it is free to activate the postsynaptic adrenergic receptors.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesHepatic. Half Life: 9-16 hours
FDA Pharmacological Classification · 4 Einträge

PSEUDOEPHEDRINE HCL

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

PSEUDOEPHEDRINE HYDROCHLORIDE

alpha-Adrenergic Agonist [EPC]; Adrenergic alpha-Agonists [MoA]

MeSH Pharmacological Classification · 5 Einträge

Agents, usually topical, that relieve itching (pruritus).

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Verwendung und Herstellung

Uses · 1 Eintrag

For the treatment of nasal congestion, sinus congestion, Eustachian tube congestion, and vasomotor rhinitis, and as an adjunct to other agents in the optimum treatment of allergic rhinitis, croup, sinusitis, otitis media, and tracheobronchitis. Also used as first-line therapy of priapism.

Zugehörige Reaktionen

8
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 219487
HRID 219487als Eduktuspto-grants-2012_06
Reaktionsgleichung von HRID 333515
HRID 333515als Eduktuspto-grants-2014_11
Reaktionsgleichung von HRID 403100
HRID 403100als Eduktuspto-grants-2014_06
Reaktionsgleichung von HRID 1496673
HRID 1496673als Eduktuspto-grants-2015_12
Reaktionsgleichung von HRID 1629646
HRID 1629646als Eduktuspto-grants-2014_07
Reaktionsgleichung von HRID 1732428
HRID 1732428als Produktuspto-grants-1980_12
Reaktionsgleichung von HRID 1907052
HRID 1907052als Eduktuspto-grants-2013_12
Reaktionsgleichung von HRID 2195563
HRID 2195563als Eduktuspto-grants-2012_12

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
Signs and Symptoms · 1 Eintrag

Common adverse reactions include nervousness, restlessness, and insomnia. Rare adverse reactions include difficult/painful urination, dizziness/lightheadedness, heart palpitations, headache, increased sweating, nausea/vomiting, trembling, troubled breathing, unusual paleness, and weakness.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Pseudoephedrine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

General Manufacturing InformationBenzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.S)-: ACTIVE